About this trial
This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.
Eligibility criteria
Qualifiers
Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
Hoehn & Yahr stage II-III (ON-medication state);
Able to walk independently for ≥5 minutes;
Stable medication for ≥1 month;
Disqualifiers
Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
Cognitive impairments or severe behavioral symptoms;
History of stroke, severe TBI, or brain tumor;
Cardiovascular contraindications;
Trial design
Treatments tested in this trial
- Walking Tall App